(POCT) |
| 0 (0%) 10-10 19:07 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 43.39 |
| Resistance 1: | 43.09 |
| Pivot price: | 43.09 |
| Support 1: | 42.61 |
| Support 2: | 35.46 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 15 Sep 2025
Clinical Laboratory Tests Market Trends and Business Opportunities 2025-2030: Integration of POCT Technologies Expected to Reshape Diagnostic Practices and Broaden Access to Care - GlobeNewswire
Wed, 03 Sep 2025
Using the POCT real-time PCR to detect Clostridium difficile in the environment to reduce the healthcare association infection - Cambridge University Press & Assessment
Fri, 01 Aug 2025
An ultra-sensitive, multiplexed, and cost-effective POCT system for the detection of co-infecting respiratory viruses, including SARS-CoV-2, Flu A, Flu B, and RSV, within 30 min - ScienceDirect.com
Mon, 30 Jun 2025
Design and Development of a Syringe-Based POCT Prototype Using Track-Etched PET Membranes for Simple and Rapid Detection of Group A Rotavirus in Human Samples - ACS Publications
Thu, 29 May 2025
The rise of point-of-care testing - Parkview Health
Sat, 10 May 2025
Procalcitonin POCT Cuts COPD Antibiotic Use 22% - Physician's Weekly
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
